SAGE Therapeutics
Latest round
- Series C
Last raised
- Mar 2014
Total raised
- $83M
Investors
- 5
About SAGE Therapeutics
Established in 2010 and based in Massachusetts, US, SAGE Therapeutics develops medicines for debilitating and disabling central nervous system disorders.
Who invested in SAGE Therapeutics
5 investors across 3 rounds
See all investors in SAGE Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SAGE Therapeutics
Who invested in SAGE Therapeutics?
SAGE Therapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SAGE Therapeutics raised?
SAGE Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did SAGE Therapeutics last raise money?
SAGE Therapeutics's most recent round on record is a Series C, in Mar 2014.
What does SAGE Therapeutics do?
Established in 2010 and based in Massachusetts, US, SAGE Therapeutics develops medicines for debilitating and disabling central nervous system disorders.
Where is SAGE Therapeutics headquartered?
SAGE Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like SAGE Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at SAGE Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like SAGE Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.